Reduction of plasma mycophenolic acid (MPA) and its glucuronide (MPAG) concentrations with antibiotic treatment.

被引：6
|
作者：
Naderer, OJ [1 ]
Dupuis, RE [1 ]
Wiwattanawongsa, K [1 ]
Campbell, BJ [1 ]
Hege, SG [1 ]
Smith, PC [1 ]
Johnson, MW [1 ]
机构：
[1] UNCCH, Chapel Hill, NC USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80168-4
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII50
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [21] UPLC Analysis of Mycophenolic Acid and Its Phenol and Acyl Glucuronide Metabolites in Human Plasma
    Guo, Dong
    Xu, Lin-Yong
    Pang, Liang-Fang
    Tan, Zhi-Rong
    Han, Yang
    Yang, Hong
    Zhou, Gan
    Chen, Yao
    Ouyang, Dong-Sheng
    Zhou, Hong-Hao
    CHROMATOGRAPHIA, 2010, 72 (7-8) : 747 - 752
  • [22] Comparison of plasma and oral fluid concentrations of mycophenolic acid and its glucuronide metabolite by LC-MS in kidney transplant patients
    Lukasewicz Ferreira, Pamela C.
    Thiesen, Flavia Valladao
    de Araujo, Thaina Tavares
    D'Avila, Domingos Otavio
    Gadonski, Giovani
    de Oliveira, Carmem Silvana A.
    Zimmer, Aline Rigon
    Froehlich, Pedro Eduardo
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (04) : 553 - 559
  • [23] A high-throughput U-HPLC-MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine
    Klepacki, Jacek
    Klawitter, Jelena
    Bendrick-Peart, Jamie
    Schniedewind, Bjorn
    Heischmann, Svenja
    Shokati, Touraj
    Christians, Uwe
    Klawitter, Jost
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 883 : 113 - 119
  • [24] Investigation of the Crossreactivity of Mycophenolic Acid Glucuronide Metabolites and of Mycophenolate Mofetil in the Cedia MPA Assay
    Shipkova, Maria
    Schuetz, Ekkehard
    Besenthal, Ingo
    Fraunberger, Peter
    Wieland, Eberhard
    THERAPEUTIC DRUG MONITORING, 2010, 32 (01) : 79 - 85
  • [25] New solid phase extraction method for determination of mycophenolic acid and mycophenolic acid glucuronide in human plasma
    Cox, SL
    Cabovska, B
    Vinks, AA
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 215 - 216
  • [26] Automated determination of free mycophenolic acid and its glucuronide in plasma from renal allograft recipients
    Mandla, R
    Line, PD
    Midtvedt, K
    Bergan, S
    THERAPEUTIC DRUG MONITORING, 2003, 25 (03) : 407 - 414
  • [27] Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots
    Heinig, Katja
    Bucheli, Franz
    Hartenbach, Roswitha
    Gajate-Perez, Almudena
    BIOANALYSIS, 2010, 2 (08) : 1423 - 1435
  • [28] Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitro
    Flavia Schmidt
    Kathrin Eckardt
    Mehdi Shakibaei
    Petra Glander
    Ralf Stahlmann
    Archives of Toxicology, 2013, 87 : 361 - 370
  • [29] Population pharmacokinetic (PK) model of mycophenolic acid (MPA) and its metabolite - Mycophenolic acid glucoronide (MPAG) in long term transplant renal patients using Montecarlo parametric expectation maximization (MC-PEM).
    Okusanya, O. O.
    Dole, K.
    Zack, J.
    Forrest, A.
    Gundroo, A.
    Leca, N.
    Venuto, R. C.
    Tornatore, K. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S72 - S72
  • [30] Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitro
    Schmidt, Flavia
    Eckardt, Kathrin
    Shakibaei, Mehdi
    Glander, Petra
    Stahlmann, Ralf
    ARCHIVES OF TOXICOLOGY, 2013, 87 (02) : 361 - 370
12345